Recruitment started in May 2017 and is expected to be completed in 2021. During this period 965 patients will be randomized to the S-ICD implant with DFT or S-ICD implant without DFT
Duration of the study
The study will be completed at a median follow-up of 40 month.
Patientsare randomized in centers in Europe and the United States. All centers have qualified cardiology departments with facilities for ICD implantation and have ample experience with S-ICD implantation and DFT testing. Follow up visits are performed under routine protocols.
The PRAETORIAN-DFT trial is registered with ClinicalTrials.gov (NCT03495297).